Acropolis Investment Management LLC Sells 2,363 Shares of Pfizer Inc.

Source: https://www.dailypolitical.com/2023/12/19/acropolis-investment-management-llc-sells-2363-shares-of-pfizer-inc-nysepfe.html

Additionally, the federal government’s control over vaccines and treatments will end, potentially leading to an increase in prices with Pfizer announcing a charge of up to $130 per dose.

Source: https://healthnewstrack.com/covid-measures-set-to-expire-as-america-returns-to-normalcy_7297/

Also on Monday, Pfizer rival Moderna reaffirmed its covid vaccine sales guidance for 2023 but said it was too early to accurately project where vaccination rates would land.

Source: https://www.irishexaminer.com/business/economy/arid-41251459.html

Also on Wednesday, chief medical officer of health Dr. Mark Joffe announced the availability of the Pfizer bivalent vaccine booster for kids aged five to 11 and the Novavax shot was available for kids 12 to 17.

Source: https://globalnews.ca/news/9393846/alberta-covid-numbers-january-hospitalizations/

Amplius Wealth Advisors LLC’s holdings in Pfizer were worth $1,164,000 at the end of the most recent quarter.

Source: https://www.dailypolitical.com/2023/12/27/amplius-wealth-advisors-llc-sells-1072-shares-of-pfizer-inc-nysepfe.html

An advisory panel to the Meals and Drug Administration voted on Thursday in favor of approving a vaccine by Pfizer to stop the extreme respiratory virus that could be a probably lethal risk to infants.

Source: https://www.mccourier.com/fda-panel-recommends-rsv-vaccine-to-protect-young-infants/

Analysts anticipate that Pfizer Inc. will post 6.46 earnings per share for the current fiscal year.

Source: https://www.americanbankingnews.com/2023/01/15/beaumont-asset-management-l-l-c-has-1-26-million-stock-holdings-in-pfizer-inc-nysepfe.html

A Pfizer spokesperson said the $US90 billion referred to the combined obesity and diabetes markets for the GLP-1 class of drugs.

Source: https://www.theage.com.au/business/companies/obesity-treatments-the-new-pharma-frontier-20230115-p5ccli.html?ref=rss&utm_medium=rss&utm_source=rss_business

Aprio Wealth Management LLC’s holdings in Pfizer were worth $1,547,000 at the end of the most recent reporting period.

Source: https://www.dailypolitical.com/2023/09/21/aprio-wealth-management-llc-increases-holdings-in-pfizer-inc-nysepfe.html

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc and German partner BioNTech’s updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to preliminary data analyzed by U.S. health authorities.

Source: https://financialpost.com/pmn/business-pmn/u-s-fda-cdc-see-early-signal-of-possible-pfizer-bivalent-covid-shot-link-to-stroke

As a group, equities research analysts expect that Pfizer Inc. will post 1.56 EPS for the current year.

Source: https://www.etfdailynews.com/2023/11/19/financial-partners-group-llc-trims-stock-position-in-pfizer-inc-nysepfe/

As a prescription medication, Paxlovid’s purchase channel will strictly align with government regulations, Pfizer said.

Source: https://businessmirror.com.ph/2023/01/09/chinas-soaring-covid-cases-send-people-to-black-market-for-remedy/

A staff member draws up a syringe with the Comirnaty vaccine from Biontech and Pfizer adapted to the Omicron-BA.1 variant at the Mainz vaccination center.

Source: https://biztoc.com/x/12d27945a44ff69d?ref=ff

Atlantic Securities decreased their target price on shares of Pfizer from $50.00 to $46.00 and set a “neutral” rating for the company in a research report on Wednesday, February 1st.

Source: https://www.americanbankingnews.com/2023/04/07/acas-llc-acquires-new-holdings-in-pfizer-inc-nysepfe.html

Atlantic Securities dropped their price target on Pfizer from $50.00 to $46.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 1st.

Source: https://www.americanbankingnews.com/2023/03/21/foundation-resource-management-inc-sells-754-shares-of-pfizer-inc-nysepfe.html

A tornado in North Carolina damaged a Pfizer pharmaceutical plant.

Source: https://nypost.com/2023/07/19/pfizer-reports-north-carolina-pharmaceutical-plant-damaged-by-tornado-no-serious-injuries/

Avantax Advisory Services Inc. raised its position in Pfizer Inc. () by 6.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).

Source: https://www.americanbankingnews.com/2023/01/16/avantax-advisory-services-inc-raises-position-in-pfizer-inc-nysepfe.html

Bank Julius Baer & Co. Ltd Zurich boosted its holdings in Pfizer by 98,197.9% during the second quarter.

Source: https://www.dailypolitical.com/2023/10/07/calton-associates-inc-purchases-4356-shares-of-pfizer-inc-nysepfe.html

Bank Julius Baer & Co. Ltd Zurich’s holdings in Pfizer were worth $104,055,000 at the end of the most recent reporting period.

Source: https://www.americanbankingnews.com/2023/04/02/bank-julius-baer-co-ltd-zurich-purchases-1442063-shares-of-pfizer-inc-nysepfe.html

Barclays decreased their target price on Pfizer from $43.00 to $40.00 in a research note on Wednesday, May 3rd.

Source: https://www.americanbankingnews.com/2023/06/18/cedar-brook-financial-partners-llc-increases-position-in-pfizer-inc-nysepfe.html